All Insiders Activity for ImmunoGen Inc. (IMGN)

$ 4.625   -0.175 (-3.65%) Volume: 1.73m 3:38 PM EDT 29-May-2020
Name: Transaction:
Date Name: Shares Transaction Value
04/02/20 David G. Foster,
V.P.-Fin., Prin. Acctg. Off.
5,448 Sell at $3.43 per share. $18,687
04/01/20 David G. Foster,
V.P.-Fin., Prin. Acctg. Off.
18,160 Option Exercise at $0.00 per share. $0
02/24/20 Anna Berkenblit,
SVP & Chief Medical Officer
25,803 Sell at $4.99 per share. $128,757
02/24/20 Theresa Wingrove,
SVP of Regulatory Affairs
16,147 Sell at $4.99 per share. $80,574
02/24/20 Mark J. Enyedy,
Director, Chief Executive Officer
55,222 Sell at $4.99 per share. $275,558
02/24/20 Thomas Ryll,
SVP, Technical Operations
16,790 Sell at $4.99 per share. $83,782
02/24/20 Craig Barrows,
Executive VP, General Counsel
16,492 Sell at $4.99 per share. $82,295
12/31/19 David G. Foster,
V.P.-Fin., Prin. Acctg. Off.
662 Acqusition at $1.99 per share. $1,317
12/31/19 Theresa Wingrove,
SVP of Regulatory Affairs
4,762 Acqusition at $1.99 per share. $9,476
07/01/19 Craig Barrows,
Executive VP, General Counsel
5,230 Acqusition at $1.84 per share. $9,623
07/01/19 Blaine McKee,
EVP & Chief Business Officer
5,230 Acqusition at $1.84 per share. $9,623
07/01/19 Thomas Ryll,
SVP, Technical Operations
5,230 Acqusition at $1.84 per share. $9,623
07/01/19 David G. Foster,
V.P.-Fin., Prin. Acctg. Off.
3,536 Acqusition at $1.84 per share. $6,506
07/01/19 Mark J. Enyedy,
Director, Chief Executive Officer
5,230 Acqusition at $1.84 per share. $9,623
07/01/19 Anna Berkenblit,
SVP & Chief Medical Officer
5,230 Acqusition at $1.84 per share. $9,623
  Page 1 of 16   Next Page
View Section 16 Filings (Forms 3,4,5) for IMGN Insider Summary For IMGN